| Literature DB >> 23273723 |
Andrew N Coogan1, Barbora Schutová, Susanne Husung, Karolina Furczyk, Bernhard T Baune, Peter Kropp, Frank Häßler, Johannes Thome.
Abstract
Alzheimer's disease (AD) is a devastating neurodegenerative condition associated with severe cognitive and behavioral impairments. Circadian rhythms are recurring cycles that display periods of approximately 24 hours and are driven by an endogenous circadian timekeeping system centered on the suprachiasmatic nucleus of the hypothalamus. We review the compelling evidence that circadian rhythms are significantly disturbed in AD and that such disturbance is of significant clinical importance in terms of behavioral symptoms. We also detail findings from neuropathological studies of brain areas associated with the circadian system in postmortem studies, the use of animal models of AD in the investigation of circadian processes, and the evidence that chronotherapeutic approaches aimed at bolstering weakened circadian rhythms in AD produce beneficial outcomes. We argue that further investigation in such areas is warranted and highlight areas for future research that might prove fruitful in ultimately providing new treatment options for this most serious and intractable of conditions.Entities:
Keywords: Alzheimer’s disease; SCN; chronotherapy; circadian; dementia; sleep
Mesh:
Year: 2012 PMID: 23273723 DOI: 10.1016/j.biopsych.2012.11.021
Source DB: PubMed Journal: Biol Psychiatry ISSN: 0006-3223 Impact factor: 13.382